GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GB Sciences Inc (OTCPK:GBLX) » Definitions » Cyclically Adjusted PB Ratio

GB Sciences (GB Sciences) Cyclically Adjusted PB Ratio : 1.00 (As of Jun. 06, 2024)


View and export this data going back to 2003. Start your Free Trial

What is GB Sciences Cyclically Adjusted PB Ratio?

As of today (2024-06-06), GB Sciences's current share price is $0.01. GB Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $0.01. GB Sciences's Cyclically Adjusted PB Ratio for today is 1.00.

The historical rank and industry rank for GB Sciences's Cyclically Adjusted PB Ratio or its related term are showing as below:

GBLX' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0.86
Current: 0.86

During the past years, GB Sciences's highest Cyclically Adjusted PB Ratio was 0.86. The lowest was 0.00. And the median was 0.00.

GBLX's Cyclically Adjusted PB Ratio is ranked better than
65.96% of 661 companies
in the Biotechnology industry
Industry Median: 1.75 vs GBLX: 0.86

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

GB Sciences's adjusted book value per share data for the three months ended in Dec. 2023 was $-0.012. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.01 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


GB Sciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for GB Sciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GB Sciences Cyclically Adjusted PB Ratio Chart

GB Sciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

GB Sciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.44

Competitive Comparison of GB Sciences's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, GB Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GB Sciences's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GB Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where GB Sciences's Cyclically Adjusted PB Ratio falls into.



GB Sciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

GB Sciences's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.01/0.01
=1.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GB Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, GB Sciences's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.012/129.4194*129.4194
=-0.012

Current CPI (Dec. 2023) = 129.4194.

GB Sciences Quarterly Data

Book Value per Share CPI Adj_Book
201403 -0.139 99.695 -0.180
201406 0.083 100.560 0.107
201409 0.059 100.428 0.076
201412 0.033 99.070 0.043
201503 -0.047 99.621 -0.061
201506 -0.029 100.684 -0.037
201509 -0.009 100.392 -0.012
201512 -0.024 99.792 -0.031
201603 -0.040 100.470 -0.052
201606 -0.011 101.688 -0.014
201609 0.027 101.861 0.034
201612 0.039 101.863 0.050
201703 0.067 102.862 0.084
201706 0.057 103.349 0.071
201709 0.059 104.136 0.073
201712 0.065 104.011 0.081
201803 0.076 105.290 0.093
201806 0.072 106.317 0.088
201809 0.058 106.507 0.070
201812 0.045 105.998 0.055
201903 0.034 107.251 0.041
201906 0.028 108.070 0.034
201909 0.021 108.329 0.025
201912 0.031 108.420 0.037
202003 0.000 108.902 0.000
202006 -0.006 108.767 -0.007
202009 -0.008 109.815 -0.009
202012 -0.009 109.897 -0.011
202103 -0.005 111.754 -0.006
202106 -0.006 114.631 -0.007
202109 -0.008 115.734 -0.009
202112 0.006 117.630 0.007
202203 -0.005 121.301 -0.005
202206 -0.007 125.017 -0.007
202209 -0.003 125.227 -0.003
202212 -0.004 125.222 -0.004
202303 -0.012 127.348 -0.012
202306 -0.012 128.729 -0.012
202309 -0.012 129.860 -0.012
202312 -0.012 129.419 -0.012

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


GB Sciences  (OTCPK:GBLX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


GB Sciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of GB Sciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GB Sciences (GB Sciences) Business Description

Traded in Other Exchanges
Address
9205 W. Russell Road, Suite 240, Las vegas, NV, USA, 89148
GB Sciences Inc is active in the healthcare sector. The company is engaged in developing and utilizing technologies in plant biology, cultivation, and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates, and cannabinoid therapies. It seeks to be a technology and solution company that converts the cannabis plant into medicines, therapies, and treatments for a range of ailments.
Executives
John C Poss director, officer: Chief Executive Officer
Craig Ellins director, 10 percent owner, officer: CEO 3035 EAST PATRICK LANE, SUITE 9, LAS VEGAS NV 89120
Lazarus Management Co Llc 10 percent owner 260 N. JOSEPHINE STREET, SUITE 300, DENVER CO 80206
Lazarus Israel Opportunities Fund Lllp 10 percent owner C/O IBEX GP LLC, 260 NORTH JOSEPHINE STREET, SUITE 300, DENVER CO 80206
Lazarus Investment Partners Lllp 10 percent owner C/O IBEX INVESTORS LLC, 260 NORTH JOSEPHINE STREET, SUITE 300, DENVER CO 80206
Justin B Borus 10 percent owner 260 N. JOSEPHINE STREET, SUITE 300, DENVER CO 80206

GB Sciences (GB Sciences) Headlines

From GuruFocus

Gb Sciences Completes $8 Million Sale of Las Vegas Cannabis Facility

By GuruFocusNews GuruFocusNews 01-11-2022